DSGN
Design Therapeutics·NASDAQ
--
--(--)
--
--(--)
DSGN fundamentals
Design Therapeutics (DSGN) released its earnings on Aug 7, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.34 (YoY -61.90%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.34
-61.90%
Report date
Aug 7, 2025
EPS
Actual | -0.31 | -0.14 | -0.21 | -0.2 | -0.24 | -0.27 | -0.32 | -0.31 | -0.35 | -0.36 | -0.28 | -0.21 | -0.2 | -0.21 | -0.23 | -0.24 | -0.31 | -0.34 |
Forecast | -0.2367 | -0.18 | -0.14 | -0.2267 | -0.22 | -0.25 | -0.288 | -0.344 | -0.358 | -0.3975 | -0.4075 | -0.31 | -0.2633 | -0.2333 | -0.2433 | -0.2667 | -0.28 | -0.33 |
Surprise | -30.97% | +22.22% | -50.00% | +11.78% | -9.09% | -8.00% | -11.11% | +9.88% | +2.23% | +9.43% | +31.29% | +32.26% | +24.04% | +9.99% | +5.47% | +10.01% | -10.71% | -3.03% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Design Therapeutics’s earnings call?What guidance did Design Therapeutics's management provide for the next earnings period?What is the market's earnings forecast for Design Therapeutics next quarter?What does Design Therapeutics do and what are its main business segments?What is Design Therapeutics's latest dividend and current dividend yield?Did Design Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Design Therapeutics's earnings call?What is Design Therapeutics's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
